Environmental Estrogens
Author(s) -
Mary S. Wolff
Publication year - 1995
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.2307/3432386
Subject(s) - xenoestrogen , medicine , public health , environmental health , cancer , breast cancer , estrogen receptor , pathology
Environmental Estrogens The estrogenic equivalent analysis that Dr. Safe presented recently in EHP (103:346351) is a welcome addition to the literature, and development of this toxicologic approach is an important step in evaluating new endpoints for environmental agents (1,2). The hormonal potential of chemical contaminants offers many opportunities for further research, including study of the environmental etiology of breast cancer. Complex mixtures are of great importance for human environmental exposures, but we understand neither exposure nor effect very well. Safe, as a basis for evaluating one hormonal endpoint, offers estrogenic equivalents acting in an additive fashion. In future research, we need to learn whether these combinations of chemicals, such as DDT and estrogen, may be additive or multiplicative. Examples of both exist. Thus, in vitro assays using MCF7 breast tumor cells found an additive effect for 10 pesticides (3), and in vivo assays of two PCB metabolites produced an apparent multiplicative effect in altering gender determination in turtles (4). We also need to investigate hormonally active compounds for other relevant biological activity. For example, vinclozilin has androgenic potential (5); genistein may act as a free radical scavenger (6); and pp'DDE demonstrated potent anti-androgenic responses in the rat (8). Estrogenicity of genistein and other phytoestrogens may be relevant to breast cancer, but countries with high dietary intake of such compounds are generally at low risk for breast cancer. Therefore, it is possible that exogenously derived phytoestrogens act differently from steroid hormones, perhaps by altering levels of free versus bound estrogen or by increasing estrogen excretion through the biliary/fecal route (8). It has become more and more apparent that toxicokinetics of chemicals is a critical component of dose-response relationships. Endogenous levels of organochlorines in women today are 10-fold higher than those of estrogen (9), and their effects are prolonged because of their persistence in the body. Toxicokinetics are also closely tied to PCB toxicity (1(1); thus 2,2',5,5'-tetra-
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom